Biogen Spinraza Treatment Delays Show COVID-19 Is Already Impacting Hospital Treatments
Biogen confirmed that some patients treated with Spinraza are temporarily having their dosing postponed as hospital systems brace for COVID-19, potentially a broader issue for the industry.